REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Hanseatic Pharma Ecuatoriana S.A. (Ecuador)

Main Activities: Pharmacies and Drug Stores
Secondary Activities: Chemical and Allied Products Merchant Wholesalers | Health and Personal Care Stores
Full name: Hanseatic Pharma Ecuatoriana S.A. Profile Updated: May 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Hanseatic Pharma Ecuatoriana S.A. is based in Ecuador, with the head office in Quito. It operates in the Pharmacies and Drug Stores sector. It was first established on September 17, 2018. It currently has a total number of 6 (2021) employees. In 2022, the company reported a net sales revenue increase of 14.77%. Its’ total assets recorded a growth of 28.44%.

Headquarters
Av de los Shyris N32-40
Quito; Pichincha;

Contact Details: Purchase the Hanseatic Pharma Ecuatoriana S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Hanseatic Pharma Ecuatoriana S.A. report to view the information.
Outstanding Shares:
Purchase the Hanseatic Pharma Ecuatoriana S.A. report to view the information.
Registered Capital:
Purchase the Hanseatic Pharma Ecuatoriana S.A. report to view the information.
Incorporation Date:
September 17, 2018
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
99%
Purchase this report to view the information.
1%
Subsidiaries
Smartpharma International Cia.Ltda
20%
Company Performance
Financial values in the chart are available after Hanseatic Pharma Ecuatoriana S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
14.77%▲
Total operating revenue
14.79%▲
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
28.44%▲
Total equity
43.71%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Quick Ratio
0.11%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo